Zimmer (NYSE:ZMH) announced U.S. commercialization for its next-generation Optio-C cervical implant, calling the device a vital milestone future development.
Minnesota-based Zimmer unveiled launch plans during this weeks’ meeting of the American Assn. for Neurological Surgeons in San Francisco, where the new device was on display.
The Optio-C technology boasts the strength, stability and fusion potential of anterior cervical discectomy and fusion surgery in a stand-alone, "no profile" system, Zimmer said.
The minimal profile of the device protects soft tissue from irritation and eliminates the need for extra plating when treating adjacent areas, according to the company. The implant is comprised of a single spacer, one plate and 3 bone screws.
"With plate strength equivalent to a traditional cervical plate, stability through a 3-screw fixation design, and fusion delivered by a spacer featuring a load-sharing interface, the Optio-C System takes cervical stand-alone devices to the next level," Zimmer Spine president Steve Healy said in prepared remarks. "This internally developed device is an important platform for future product development."
The Optio-C implant won updated FDA clearance in January 2014 for stand-alone cervical interbody fusion procedures, providing skeletal support in adults.
